P063: Uptake and clinical actionability of a genome first cancer and cardiometabolic risk stratification population health pilot in the workplace*
Abstract
Cancer and cardiometabolic diseases are the leading causes of morbidity and mortality, as well as decreased productivity and cost drivers for employers. Risk assessment, prevention and screening guidelines are readily available but underutilized. Lack of timely interventions results in more late and complex disease identification, expensive treatment and lower survival rates. Population-based genetic testing strategies outperform clinical criteria and family history strategies. ACMG guidelines suggest reporting of actionable cancer and cardiometabolic findings.
Fields of Study & Subjects
BRCA gene mutations in cancer
Genomics and Rare Diseases
Cancer Genomics and Diagnostics
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 103554–103554
- Publication date
- 1 January 2026
- Language
- EN